10XBeta

10XBeta operates as a venture studio and product development firm with a pronounced focus on the medical technology sector. Established in 2010 by CEO Marcel Botha and COO Frederick Kruger, the company is headquartered in Brooklyn, New York. Botha, an entrepreneur and investor with a background in architecture and engineering from MIT, specializes in guiding product development from concept to viable product. His journey includes co-founding Infant Ventures LLC in 2012, known for the Spuni feeding product, and Patients Pending Ltd, where he developed Timesulin to aid diabetics. Kruger is an internationally recognized product development expert with two decades of experience in innovation, design, and intellectual property commercialization.

The firm's business model is centered on a vertically integrated approach to building healthcare companies that connect devices, data, and AI to provide continuous insights and improve patient outcomes. 10XBeta engages in co-investment, provides early capital to kickstart commercialization, develops both the product and the business, and offers in-house manufacturing to help startups scale from prototype to full production. This model is designed to de-risk medical device innovation by aligning with market needs and FDA requirements from the beginning, validating concepts early, and planning for production proactively. Revenue is generated through founder and preferred equity investments in the startups it helps form, as well as from its shared product development, design, engineering, and manufacturing services.

10XBeta serves a range of clients, from startups to established organizations, guiding them from initial concepts to regulatory-cleared medical devices and market-ready companies. A significant achievement was their role in the Emergency Ventilator Response team during the COVID-19 pandemic, where they were pivotal in the development of the Spiro Wave ventilator for New York City in March 2020. Their portfolio is diverse, including pulmonary technology, drug delivery systems, telehealth services, and first responder technologies. The company utilizes proprietary Medical Device Development Tools (MDDT) to streamline the journey from concept to market, reducing risk and time-to-revenue for its portfolio companies.

Keywords: venture studio, medical device development, HealthTech, product commercialization, connected medical devices, concept to market, regulatory clearance, MedTech innovation, hardware development, startup incubation, product engineering, in-house manufacturing, prototype to production, digital health, telehealth services, drug delivery systems, medical device design, FDA compliance, early-stage investment, financial modeling, capital planning, go-to-market strategy, intellectual property commercialization, Marcel Botha, Frederick Kruger